QDEL Quidel Corp

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.

$97.11  -0.07 (-0.07%)
As of 07/01/2022 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  03/02/2001
Outstanding shares:  41,848,256
Average volume:  705,335
Market cap:   $4,066,813,518
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BM9VY27

---

Valuation   (See tab for details)

---

PE ratio:   4.04
PB ratio:   2.10
PS ratio:   1.75
Return on equity:   41.66%
Net income %:   43.26%